Price $2.21 |
Market Cap
50.9M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
0.57
|
P/S
120.37
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-32.7K
|
FCF
-0.7
|
|
Op. Margin
-
|
Net Margin
-
|
ROE
-39.40%
|
ROI
-37.50%
|
|
ROA
-35.70%
|
EPS Growth
1.00%
|
Current Ratio
14.3
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Owens & Minor, Inc. (OMI) | $15.72 | - | - | 1.19B | Strong Buy |
| Navidea Biopharmaceuticals Inc (NAVB) | $0.00 | - | - | 5M | Strong Buy |
| Cidara Therapeutics Inc (CDTX) | $11.55 | - | - | 78M | Strong Buy |
| Chromadex Corp (CDXC) | $3.26 | - | - | 105.8M | Strong Buy |
| Myomo Inc (MYO) | $3.77 | - | - | 35.8M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
